Literature DB >> 3351141

Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy.

Z Sasson1, P G Yock, L K Hatle, E L Alderman, R L Popp.   

Abstract

The continuous wave Doppler ultrasound signal across the left ventricular outflow tract in hypertrophic cardiomyopathy has a characteristic pattern that is in keeping with the dynamic nature of the pressure gradient in this condition. To determine the accuracy and reliability of the peak Doppler flow velocity signal for measuring the peak pressure gradient in this condition, 340 beats were analyzed from five consecutive patients studied with simultaneous continuous wave Doppler ultrasound and dual catheter pressure recordings across the left ventricular outflow tract. Each patient was studied at steady state and during physiologic and pharmacologic manipulations of the pressure gradient. Peak velocity and calculated peak gradient were determined by two independent observers who did not know the catheter measurements. In addition, 18 beats with well defined flow velocity envelopes were digitized for analysis of the magnitude, timing and contour of the instantaneous Doppler ultrasound and catheter gradients throughout systole. Peak catheter gradient in the 340 beats ranged from 12 to 245 mm Hg. The correlations between the Doppler-derived and catheter peak gradients were close (r = 0.96, SEE = 4 mm Hg for Observer 1 and r = 0.97, SEE = 11 mm Hg for Observer 2). Interobserver variability for measurement of peak flow velocity was small (mean +/- SD 0.16 +/- 0.15 m/s). An interobserver difference greater than 0.3 m/s occurred in 25 of the 340 beats analyzed. By retrospective analysis, this was due to contamination of the outflow tract signal by mitral regurgitation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3351141     DOI: 10.1016/0735-1097(88)90207-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  17 in total

1.  Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation.

Authors:  Felix Y j Keng; Su Min Chang; Eduardo Cwajg; Zuo-Xiang He; Nasser M Lakkis; Sherif F Nagueh; William H Spencer; Mario S Verani
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

2.  Ventricular dysfunction in hypertrophic obstructive cardiomyopathy.

Authors:  R D Leachman
Journal:  Tex Heart Inst J       Date:  1991

Review 3.  Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.

Authors:  Waseem Hindieh; Raymond Chan; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

4.  A potential role of caspase recruitment domain family member 9 (Card9) in transverse aortic constriction-induced cardiac dysfunction, fibrosis, and hypertrophy.

Authors:  Matthew R Peterson; Yohannes Getiye; Luiza Bosch; Alyssa J Sanders; Aspen R Smith; Samantha Haller; Kayla Wilson; D Paul Thomas; Guanglong He
Journal:  Hypertens Res       Date:  2020-07-09       Impact factor: 3.872

5.  Long-term survival after acute myocardial infarction in patients with hypertrophic cardiomyopathy.

Authors:  Yin-Jian Yang; Chao-Mei Fan; Jin-Qing Yuan; Hai-Bin Zhang; Fu-Jian Duan; Zhi-Min Wang; Xi-Ying Guo; Shan-Shan Zhai; Shuo-Yan An; Fei Hang; Yi-Shi Li
Journal:  Clin Cardiol       Date:  2016-10-17       Impact factor: 2.882

6.  Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration.

Authors:  F Cecchi; A Montereggi; I Olivotto; P Marconi; A Dolara; B J Maron
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

7.  In vivo measurement of mitral leaflet surface area and subvalvular geometry in patients with asymmetrical septal hypertrophy: insights into the mechanism of outflow tract obstruction.

Authors:  Dae-Hee Kim; Mark D Handschumacher; Robert A Levine; Yun-Sil Choi; Yun Jeong Kim; Sung-Cheol Yun; Jong-Min Song; Duk-Hyun Kang; Jae-Kwan Song
Journal:  Circulation       Date:  2010-09-13       Impact factor: 29.690

8.  Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.

Authors:  Mengyao Zhou; Shengjun Ta; Rebecca T Hahn; David H Hsi; Martin B Leon; Rui Hu; Jun Zhang; Lei Zuo; Jing Li; Jing Wang; Bo Wang; Xiaoli Zhu; Jiani Liu; Yupeng Han; Xiaojuan Li; Bo Xu; Lei Zhang; Lihong Hou; Chao Han; Jincheng Liu; Liwen Liu
Journal:  JAMA Cardiol       Date:  2022-05-01       Impact factor: 30.154

Review 9.  Role of cardiac ultrasound in the assessment of hypertrophic cardiomyopathy.

Authors:  P Spirito
Journal:  Int J Card Imaging       Date:  1993

10.  Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography.

Authors:  Osama I I Soliman; Paul Knaapen; Marcel L Geleijnse; Pieter A Dijkmans; Ashraf M Anwar; Attila Nemes; Michelle Michels; Wim B Vletter; Adriaan A Lammertsma; Folkert J ten Cate
Journal:  Heart       Date:  2007-05-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.